XML 52 R34.htm IDEA: XBRL DOCUMENT v3.22.0.1
FAIR VALUE MEASUREMENTS (Details)
$ / shares in Units, $ in Millions
1 Months Ended 12 Months Ended
Mar. 31, 2010
USD ($)
item
$ / shares
Dec. 31, 2021
Manhattan and Ariston Pharmaceuticals Merger [Member]    
Fair Value Measurement [Line Items]    
Notes Issued | $ $ 15.5  
Debt instrument, term 5 years  
Det instrument rate 5.00%  
Debt Instrument convertible conversion price | $ / shares $ 1,125  
Percentage of cash proceeds from operation to repay convertible debt 5.00%  
Number of obligations | item 0  
Convertible Notes Payable [Member]    
Fair Value Measurement [Line Items]    
Det instrument rate   5.00%